[Use of oral contraceptives and increased risk of cervical cancer].
A recently published meta-analysis and a large cohort study showed independently that use of oral contraceptives (OC) leads to an increased relative risk (RR) of cervical cancer. This RR increased with the duration of OC use and was 1.90 after 5 years or more (95% CI: 1.69-2.13). The increased RR decreased after cessation of OC use and was normal again Io years later. Longstanding OC use enhances human papillomavirus (HPV) transcription and decreases HPV clearance, resulting in more frequent persistence of HPV, an increase of cervical intraepithelial neoplasia, and an increased RR of cervical cancer. The increase in cervical cancer by OC is, however, associated with a fully compensatory decrease in the incidence of other malignancies, in particular ovarian cancer and endometrial cancer. Based on these findings, there are no reasons to discourage the use of OC by women in the Netherlands.
Schmeink
C E
CE
Universitair Medisch Centrum St Radboud, afd. Verloskunde en Gynaecologie, Postbus 9101, 6500 HB Nijmegen.
Lenselink
C H
CH
Bekkers
R L M
RL
D003276:Contraceptives, Oral / Q000008:administration & dosage* / Q000009:adverse effects*; D016889:Endometrial Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000517:prevention & control; D012307:Risk Factors; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000821:virology
D003276:Contraceptives, Oral